Loading

Perception and Use of Smoking Cessation Methods Stratified by Patient Characteristics: A Pilot Study

Research Article | Open Access | Volume 5 | Issue 3

  • 1. Melrose Wakefield Healthcare, USA1
  • 2. Department of Pharmacy Practice, MCPHS University Worcester/Manchester School of Pharmacy, USA
  • 3. Department of Pharmaceutical Sciences, MCPHS University Worcester/Manchester School of Pharmacy, USA
+ Show More - Show Less
Corresponding Authors
Audrey A. Abelleira, PGY1 Pharmacy Resident, Melrose Wakefield Healthcare, Medford, MA, 2018 graduate of MCPHS University Worcester/Manchester School of Pharmacy, Manchester, NH, USA
Abstract

An anonymous survey was administered to a convenience sample to investigate attitudes surrounding tobacco cigarette smoking cessation methods in relation to characteristic information, elucidate which patient populations may be more likely to favor unassisted or assisted cessation, and identify areas where further patient education may be necessary.

Of 131 participants surveyed, 6% were current smokers, 24% former smokers, and 65% never smoked. On average, participants could recall two evidence-based cessation methods. Unassisted cessation (45.8%) and nicotine replacement therapy (NRT) (43.51%) ranked highest in familiarity. Unassisted (32.82%), counseling (29.77%), and NRT (23.66%) ranked most effective. Participants were more likely to view physicians as cessation resources compared to pharmacists (p=0.015). Age and education affected whether participants indicated physicians (p=0.003, p<0.001, respectively) or pharmacists (p=0.018, p=0.003, respectively) were cessation resources. Participants over age 60 (p<0.001), without a high school diploma (p=0.004), or current smokers (p=0.053) were more likely to agree that unassisted quitting signified greater commitment. Participants over 60 were less positive about the usefulness of NRT compared to participants ages 18-24 (p=0.009) and 25-30 (p=0.046).

Participants indicated that unassisted smoking cessation was the most well-known and effective method. Awareness of cessation methods and their proper utilization was poor across all characteristic subsets. Age and education influenced attitudes toward available cessation resources. Despite pharmacists being easily accessible, these results indicate that more education is needed for pharmacists to be more widely regarded as resources for cessation. Providers need to be mindful of these factors when discussing options for tobacco cigarette smoking cessation.

Keywords

• Smoking cessation
• Pharmacist
• Cigarettes
• Nicotine

Citation

Abelleira AA, Morrill AM, Abel C, Goldsmith CA (2018) Perception and Use of Smoking Cessation Methods Stratified by Patient Characteristics: A Pilot Study. Ann Public Healtth Res 5(3): 1082.

ABBREVIATIONS

NRT: Nicotine Replacement Therapy; RX: Prescription; E-cigs: Electronic Cigarettes

INTRODUCTION

Unassisted tobacco cigarette smoking cessation, executed by limiting tobacco consumption abruptly or gradually, or by replacing tobacco cigarettes with electronic cigarettes, is the most popular option for smoking cessation [1]. The preference for unassisted smoking cessation persists despite evidence indicating improved results from the combination of behavioral counseling with the use of nicotine replacement therapy (NRT) or other pharmacological aids [1,2]. Current tobacco dependence treatment guidelines recommend a combination of both pharmacological and non-pharmacological cessation aids [2].

Smokers’ attitudes may play a role in the choice of unassisted smoking cessation. For example, willpower and the desire and commitment to quit are considered prerequisites for a successful quit attempt [3-7]. Additionally, smokers have expressed the belief that quitting smoking was their personal responsibility and that unassisted cessation was the right way to do so [7]. Quitting unassisted exemplifies the values of self-reliance, independence, autonomy, and strength, and allows smokers to feel as though they have achieved something by quitting without aids [4,7]. For some smokers, smoking is not viewed as an illness, and thus seeking treatment from a medical professional seems unnecessary [3,7]. For others, the decision against cessation aids may be due to a lack of awareness of the options available for smoking cessation treatment [8].

The resistance to using pharmacological aids may be attributed to misconceptions surrounding the safety and role of these pharmacological aids in smoking cessation treatment [3,4,6-9]. Smokers feel that cessation aids will not be effective unless the requisite willpower and desire to quit are present, demonstrating a lack of understanding of the role of cessation aids in helping smokers increase their readiness to quit [6]. A common concern regarding cessation aids stems from the disconnect between understanding the physical dependence on nicotine and the psychological habit of smoking; thus, patients may question the efficacy of cessation aids, as they do not feel the treatment is helping to break the habit of smoking, only addressing the nicotine dependence [4,9]. NRT was most often endorsed by smokers as a method that would be efficacious for those whose nicotine dependence was only physical, without a psychological component [4]. Patients often incorrectly use cessation aids, particularly NRT, both by using NRT for shorter durations and at lower doses than indicated [4,6]. Additionally, the belief that one is transferring the addiction from cigarettes to NRT has contributed to the concern that using NRT is only delaying the quitting process [6].

Smokers have shown a preference for lay knowledge about smoking cessation, acquired through either their own experiences or the experiences of family and friends, over information presented to them by a medical professional [7]. Previous studies indicated in general, recollections of acquaintances’ use of cessation aids was negative, focusing on side effects that had been experienced; recollections of acquaintances’ experiences quitting unassisted tended to be more positive, focusing on the support provided by family and friends.7 The negative side effects of cessation aids about which patients expressed the most concern were irritability, taste (NRT), and mental health effects (bupropion, varenicline) [4].

Smokers have shown a preference for lay knowledge about smoking cessation, acquired through either their own experiences or the experiences of family and friends, over information presented to them by a medical professional [7]. Previous studies indicated in general, recollections of acquaintances’ use of cessation aids was negative, focusing on side effects that had been experienced; recollections of acquaintances’ experiences quitting unassisted tended to be more positive, focusing on the support provided by family and friends.7 The negative side effects of cessation aids about which patients expressed the most concern were irritability, taste (NRT), and mental health effects (bupropion, varenicline) [4].

While several studies have been conducted to assess attitudes of smokers toward various tobacco cessation methods, little research has been conducted to determine factors that may influence which method an individual is more likely to try and which patient populations would benefit from further education. This pilot study was conducted in Southern New Hampshire to: 1) investigate attitudes surrounding tobacco cigarette smoking cessation methods in relation to patient characteristics; 2) elucidate which patient populations may be more likely to favor unassisted or assisted cessation; and 3) provide guidance for healthcare providers to direct patient education efforts.

METHODS

An anonymous, 30-question survey (Supplementary data: Appendix A) was developed to assess participant characteristics, including smoking status and prior experiences with cigarette smoking (section 1); knowledge of, and opinions on, smoking cessation methods (section 2); prior experience with smoking cessation (section 3); and opinions on smoking cessation methods and resources (section 4). For the purposes of this study, former smokers were defined by an abstinence period of at least three months as the likelihood of maintained abstinence increases greatly once the three-month mark has been reached [10]. This was done to better capture those respondents who were beyond the early abstinence period, and in turn at increased risk of relapse, in order to add validity to any analyses comparing survey responses using smoking status as a variable. The study received exempt status from the University’s Institutional Review Board.

Participants were recruited as a convenience sample in Southern and Central New Hampshire. Data collection took place from August 10, 2017 to September 8, 2017. Sites for data collection included: community pharmacies, senior centers, and a health professions university. In order to reduce potential bias in the university setting, only newly matriculated students were eligible to complete the survey. An educational poster regarding the health effects of cigarette smoking and the benefits of quitting was used to attract participants.

Study data was analyzed using a combination of descriptive and inferential statistics. A value of alpha=0.05 was used as the threshold for significance. ANOVA with post-hoc Tukey test was used to examine the effect of characteristic differences on responses to Likert scale questions. Paired t-test was used to examine differences in perception of pharmacists and physicians as cessation resources. All data analysis was conducted using Statistical Package for the Social Sciences (SPSS).

RESULTS

Of the survey participants (n=131), the majority identified as female, and the age range with the greatest percentage of participants was 18-24 years old (Table 1).

Table 1: Participant characteristic information.

Patient Characteristics % of 
Participants
Age (years) 18-24 32.06
25-30 16.79
31-40 17.56
41-50 6.11
51-60 7.63
60+ 19.85
Education Some high school 6.11
High School 22.14
Associate’s degree 11.45
Bachelor’s degree 49.62
Advanced degree 10.69
Smoking Status Former 24.43
Current 6.87
Never 65.65
Other (electronic 
cigarettes or other 
tobacco)
3.82
Gender Female 67.94
Male 30.53
Friends and Family Who 
Smoke
Yes 87.02
No 11.02
Friends and Family Who 
Have Tried to Quit
Yes 77.86
No 18.32
Friends and Family Who 
Have Successfully Quit
Yes 69.47
No 23.66

Survey results indicate that 24.43% of participants identified as former smokers, 6.87% identified as current smokers, 65.65% indicated that they had never smoked, and 3.82% of participants indicated they used an alternative form of tobacco or electronic cigarettes.

The majority of those identifying as ex-smokers smoked for 5-10 years (25%) or 10+ years (37.5%) (Table 2).

Table 2: Smoking and cessation behavior of current and ex-smokers.

Smoking Demographics % of 
Participants
Time Smoking (exsmokers) Less than 6 months 12.5
6-12 months 0
1-5 years 21.88
5-10 years 25
10+ years 37.5
Time Since Quitting (exsmokers Less than 6 months 9.38
6-12 months 6.25
1-5 years 12.5
5-10 years 9.38
10+ years 56.25
Time Smoking (current 
smokers)
Less than 6 months 11.11
6-12 months 0
1-5 years 0
5-10 years 11.11
10+ years 77.78
Number of Quit Attempts 
(ex-smokers)
1 34.38
2 15.63
3 6.25
4 9.38
5+ 34.38
Number of Quit Attempts 
(current smokers)
Never 11.11
1 11.11
2 22.22
3 0
4 11.11
5+ 33.33
Number of Cigarettes 
Smoked Per Day (ex and 
current)
Less than 5 19.51
10-May 17.07
20-Nov 31.71
21-30 17.07
31-40 4.88
40+ 2.44

Of the exsmokers, 56.25% quit over 10 years ago. Most ex-smokers either quit on their first try (34.38%) or tried to quit 5 or more times before succeeding (34.38%). Of the current smokers surveyed, 77.78% had been smoking for over 10 years. Approximately 33% of the current smokers had tried to quit more than 5 times, and 11% had never tried to quit. Almost one-third of former and current smokers surveyed smoked 11-20 cigarettes/day.

On average, participants could recall 2 out of 5 evidencebased cessation methods. Additional non-evidence-based methods listed by participants included taking up a new hobby, vaping or using electronic cigarettes, and hypnosis (Figure 1a). There were no statistically significant relationships between age, education, or smoking status and method recall. Of survey participants, 13.74% agreed, 68.7% disagreed, and 12.98% were unsure if electronic cigarettes were a safe alternative to smoking. Age, education, and smoking status were not associated with participants’ belief that electronic cigarettes were safe.

When asked specifically about cessation methods, NRT (43.51%) and unassisted cessation (45.8%) ranked highest in familiarity among participants. Unassisted cessation (32.82%), NRT (23.66%), and counseling (29.77%) were ranked most effective (Figure 1b).

a) Methods listed and frequency of each response when  asked to recall cessation methods b) Methods chosen when asked to  indicate most familiar and most effective cessation methods

Figure : 1 a) Methods listed and frequency of each response when asked to recall cessation methods b) Methods chosen when asked to indicate most familiar and most effective cessation methods

When asked about pharmacologic cessation methods, 45.8% of participants agreed or strongly agreed with the statement that these agents cause unpleasant side effects (Table 3). In regards to soliciting more information about smoking cessation tools, participants were more likely to agree with the statement that physicians (83.2%) are smoking cessation resources than the statement that pharmacists are smoking cessation resources (75.57%; p=0.015; Table 3).

Table 3: Participant responses to Likert scale questions represented by frequency.

Statement % of 
Participants
Medications used to 
quit smoking cause 
unpleasant side effects
Strongly Agree/Agree 45.8
Undecided 38.93
Strongly Disagree/
Disagree
2.29
Strong discipline and 
willpower are necessary 
for a successful quit 
attempt
Strongly Agree/Agree 89.31
Undecided 3.82
Strongly Disagree/
Disagree
3.06
By not using medication 
or nicotine replacement 
I am more committed to 
quitting
Strongly Agree/Agree 24.43
Undecided 36.64
Strongly Disagree/
Disagree
32.06
Medications and nicotine 
replacement are useful 
tools to help me quit
Strongly Agree/Agree 60.3
Undecided 27.48
Strongly Disagree/
Disagree
6.87
My pharmacist can be a 
resource to help me quit 
smoking
Strongly Agree/Agree 75.57
Undecided 13.74
Strongly Disagree/
Disagree
4.58
My doctor can be a 
resource to help me quit 
smoking
Strongly Agree/Agree 83.2*
Undecided 6.87
Strongly Disagree/
Disagree
3.81
Greater agreement compared to pharmacist as a cessation resource (p=0.015)

Among former/current smokers, 80.49% tried unassisted quitting during their first quit attempt. Unassisted cessation (85.37%) and NRT (34.15%) were the most common methods utilized for all quit attempts; 75% of ex-smokers surveyed reported successfully quitting unassisted. Participants reported that of their friends and family who quit, the most common methods utilized were unassisted cessation (53.44%) and NRT (48.85%); 45.8% of participants reported that family and friends successfully quit unassisted. The majority of participants strongly agreed (70.99%) or agreed (18.32%) that discipline and willpower are necessary for a successful quit attempt (Table 3). Additionally, smokers were more likely than ex-smokers to agree that unassisted quitting signifies greater commitment to quitting (p=0.043; Table 4).

Table 4: Effect of participant characteristic on response to Likert scale questions.

% in category that strongly agree or agree
Statement Age (years) Education Smoking 
status
Pharmacologic 
smoking 
aids cause 
unpleasant side 
effects
18 – 24: 47.6 Some High School: 75 Former: 50
25 – 30: 54.5 High School: 48.3 Current: 66.7
31 – 40: 56.5 Associate’s Degree: 46.7 Never: 43
41 – 50: 37.5 Bachelor’s Degree: 43.1 Other: 50
51 – 60: 20 Advanced Degree: 35.7  
60+: 38.5    
Success 
requires 
strong 
willpower 
and discipline
18 – 24: 92.8 Some High School: 75 Former: 84.4
25 – 30: 90.9 High School: 82.7 Current: 77.8
31 – 40: 86.9 Associate’s Degree: 93.3 Never: 93
41 – 50: 75 Bachelor’s Degree: 93.8 Other: 50
51 – 60: 90 Advanced Degree: 85.7  
60+: 88.5    
Not using medication or NRT signifies greater commitment to quitting 18 – 24: 14.3***
(vs. 60+)
Some High School: 62.5 Former: 43.8
25 – 30: 9.1***
(vs. 60+)
High School: 27.6 Current: 33.3
31 – 40: 21.7***
(vs. 60+)
Associate’s Degree: 26.7 Never: 17.4*
(vs. current)
41 – 50: 0***
(vs. 60+)
Bachelor’s Degree: 20**
(vs. some HS)
Other: 0
51 – 60: 10***
(vs. 60+)
Advanced Degree: 14.3*
(vs. some HS)
 
60+: 69.2    
NRT and medications can be useful tools for cessation 18 – 24: 80.9**
(vs. 60+)
Some High School: 50 Former: 43.8
25 – 30: 72.7*
(vs. 60+)
High School: 48.3 Current: 77.8
31 – 40: 56.5 Associate’s Degree: 46.7 Never: 65.1
41 – 50: 37.5 Bachelor’s Degree: 73.8 Other: 0
51 – 60: 50 Advanced Degree: 42.8  
60+: 30.8    
Pharmacists as 
cessation 
resource
18 – 24: 90.5*
(vs. 60+)
Some High School: 50 Former: 65.6
25 – 30: 86.4 High School: 58.6 Current: 66.7
31 – 40: 73.9 Associate’s Degree: 80*
(vs. some HS)
Never: 80.2
41 – 50: 50 Bachelor’s Degree: 
90.8** (vs. some HS)
Other: 50
51 – 60: 70 Advanced Degree: 50  
60+: 53.8    
Physician 
as cessation resource
18 – 24: 95.2**
(vs. 60+)
Some High School: 37.5 Former: 81.2
25 – 30: 90.9*
(vs. 60+)
High School: 75.9*** (vs. 
some HS)
Current: 66.7
31 – 40: 91.3 Associate’s Degree: 80***
(vs. some HS)
Never: 86
41 – 50: 62.5 Bachelor’s Degree: 
98.5*** (vs. some HS)
Other: 50
51 – 60: 70 Advanced Degree: 57.1**
(vs. some HS)
 
60+: 61.5    
* p<0.05, **p<0.01, ***p<0.001)

Both age and education affected participants’ perceptions on smoking cessation methods (Table 4). Respondents greater than 60 years old were more in agreement with the statement “not using pharmacologic agents signifies greater commitment to quitting,” than all other age groups (p<0.001). A significant effect of age was also observed on the perception that NRT or other medication can be useful cessation tools (p=0.017); Participants who were18-24 years old and 25-30 years old were more in agreement with the statement than those participants greater than 60 years old (p=0.009 and p=0.046, respectively). There was also a significant effect of age on agreement that pharmacists can be cessation resources (p=0.018); participants aged 18-24 were more in agreement with this statement than those over 60 years old (p=0.025). A similar effect was observed with regard to physicians as cessation resources (p=0.003); participants aged 18-24 and those aged 25-30were more in agreement compared to those over 60 years old (p=0.004 and p=0.028, respectively).

Participants with less education were more in agreement that not using medication or NRT signifies greater commitment to quitting (p=0.004); specifically, participants who did not finish high school were more in agreement with that statement compared to those with bachelor’s degrees and advanced degrees (p=0.002 and p=0.011, respectively) Education level was also observed to have an effect on participants’ agreement that pharmacists can be cessation resources (p=0.003);more participants with an associate’s degree or bachelor’s degree were in agreement than those who did not finish high school (Table 4). Education level also affected participants’ perceptions about physicians as cessation resources (p<0.001). A greater proportion of participants with a high-school-level education or above were in agreement of the potential utility of physicians’ input than those who did not finish high school.

DISCUSSION

As seen in previous studies, participants in this study identified unassisted cessation as the most commonly used method [1]. Unassisted cessation was also the method with which participants were most familiar and the method they felt was most effective. Participants also indicated a high level of familiarity and perceived efficacy with NRT; however, among participants surveyed, unassisted quitting was reported as being utilized twice as often as NRT, indicating a disconnection between perceptions of smoking cessation methods and actual utilization of these methods. The overall importance of willpower for a successful attempt was consistent with previous studies, as was concerns about side effects from pharmacological aids [3- 9]. However, most participants did not feel that using cessation aids signified less commitment to quitting, indicating that the less frequent utilization of cessation aids may be multifaceted.

When asked to list potential quit tools, common themes for alternative cessation methods emerged, with several participants mentioning hypnosis, use of electronic cigarettes or vapes, and keeping busy or starting a new hobby. These results highlight, the lack of understanding of evidence-based practice among participants and emphasizes the preference for information obtained from someone other than a healthcare professional, a result that has been observed previously [7]. Given this paucity of knowledge of evidence-based tools, patients across all characteristic groups would likely benefit from further education on the cessation aids available and their place in therapy. Previous studies have demonstrated that simply being counseled on available cessation aids improved patients’ confidence in their ability to quit, their attitudes toward the different cessation methods, and their success in maintaining abstinence from tobacco products, though utilization of cessation aids was unaffected [11].

Additionally, participants did not feel as positively about pharmacists as cessation resources as they did about physicians. While physicians fit the more traditional healthcare provider role, pharmacists are easily and affordably accessible for patients. Further patient education and outreach is needed to increase the perception of pharmacists as resources for patients looking to quit smoking. Age and education level affected patient perceptions of cessation aids and of healthcare providers’ roles as resources. Generally, younger and more educated participants viewed cessation aids more favorably and were more likely to view their pharmacist or physician as a resource for cessation.

Moreover, when compared to participants who are older or have less education, younger and more educated participants were less likely to agree that use of pharmacologic agents indicated a lower commitment to quitting. Pharmacists and other healthcare providers must be mindful of these patient characteristics and attitudes when approaching the use of cessation aids with a patient. Furthermore, older patients, and those with a lower level of education would benefit from additional education and awareness regarding the use of cessation aids and their role in treatment.

This study had several limitations, primarily relating to collecting survey responses via convenience sampling. Participants were recruited as a convenience sample throughout Southern New Hampshire; as a result, the participant characteristic distribution does not represent that of the general population. Due to the sites used for data collection, most participants were either younger than age 30 or older than age 60, with little representation from middle-aged adults or teenagers under age 18. The approximately 6% of participants surveyed that were current smokers was well below the national average of approximately 18%. Additionally, there were nearly twice as many female participants as there were male participants, and socioeconomic information was not collected. The results of this pilot study may not be generalizable to the greater population, and further studies are needed to assess the external validity of the data and results obtained from the present research. Because participants were asked to complete the survey both anonymously and voluntarily, it was not possible to assess response rates or control for non response bias. Furthermore, the survey used in the present study has not been validated as an assessment tool.

Future directions for research include an examination of the effect of income on perceptions of smoking cessation methods. As the cost of most cessation aids is greater than the cost of quitting unassisted, income may play in role in which cessation method a patient chooses. Additionally, income as it relates to the cost of healthcare may influence attitudes toward utilizing physicians or pharmacists as a resource throughout the smoking cessation process.

CONCLUSION

Participants indicated that unassisted smoking cessation was the most well-known and effective cessation method, and emphasized commitment and willpower as characteristics needed to quit successfully. Awareness of evidence-based cessation methods and utilization was poor across all characteristic subsets. Age and education influenced attitudes toward available cessation resources, particularly use of pharmacologic agents. Despite pharmacists being the most accessible health care provider in the community, these results indicate that more education is needed surrounding pharmacists as resources for smoking cessation. Providers need to be mindful of these factors when discussing the utilization of healthcare professionals and of pharmacologic aids for smoking cessation with patients.

CONFLICT OF INTEREST

This study was approved by the MCPHS University Institutional Review Board committee.

REFERENCES

1. Caraballo RS, Shafer PR, Patel D, Davis KC, McAfee TA. Quit Methods Used by US Adult Cigarette Smokers, 2014-2016. Prev Chronic Dis. 2017; 14: 160600.

2. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville (MD): US Department of Health and Human Services, Public Health Service; 2008.

3. Morphett K, Lucke J, Gartner C, Carter A, Meurk C, Hall W. Public attitudes toward the treatment of nicotine addiction. Nicotine Tob Res. 2013; 15: 1617-1622.

4. Morphett K, Partridge B, Gartner C, Carter A, Hall W. Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting. Int J Environ Res Public Health. 2015; 12: 6591-6607.

5. Smith AL, Carter SM,Dunlop SM, Freeman B, Chapman S. The views and experiences of smokers who quit smoking unassisted. A systematic review of the qualitative evidence. PLoS One. 2015; 10: e0127144.

6. Silla K, Beard E, Shahab L. Nicotine replacement therapy use among smokers and ex-smokers: associated attitudes and beliefs: a qualitative study. BMC Public Health. 2014; 14: 1311.

7. Smith AL, Carter SM, Chapman S, Dunlop SM, Freeman B. Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers. BMJ Open. 2015; 5: e007301.

8. Hammond D, McDonald PW, Fong GT, Borland R. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction. 2004; 99: 1042-1048.

9. Uppal N, Shahab L, Britton J, Ratschen E. The forgotten smoker: a qualitative study of attitudes towards smoking, quitting, and tobacco control policies among continuing smokers. BMC Public Health. 2013; 13: 432.

10. Gilpin EA, Pierce JP, Farkas AJ. Duration of smoking abstinence and success in quitting. J Natl Cancer Inst. 1997; 89: 572-576.

11. Willemsen MC, Wiebing M, van Emst A, Zeeman G. Helping smokers to decide on the use of efficacious smoking cessation methods: a randomized controlled trial of a decision aid. Addiction. 2006; 101: 441-449

Abelleira AA, Morrill AM, Abel C, Goldsmith CA (2018) Perception and Use of Smoking Cessation Methods Stratified by Patient Characteristics: A Pilot Study. Ann Public Healtth Res 5(3): 1082.

Received : 24 Oct 2018
Accepted : 28 Nov 2018
Published : 30 Nov 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X